Greek study tracks Real-World use of potassium drug in kidney and heart patients

NCT ID NCT06185660

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study in Greece observed 125 patients with chronic kidney disease (on or off dialysis) or heart failure who were taking sodium zirconium cyclosilicate for high potassium levels. Researchers collected data on patient characteristics and treatment patterns over six months. The goal was to understand how the drug is used in everyday clinical practice, not to test its effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sodium zirconium cyclosilicate
What this could lead to: If successful, this study could provide insights into how best to manage high potassium levels in patients with kidney or heart conditions.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease heart failure Hyperkalemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERKALAEMIA

Contacts and locations

Locations

Research Site

Alexandroupoli, 68100, Greece
Research Site

Athens, 10676, Greece
Research Site

Athens, 11527, Greece
Research Site

Athens, 12462, Greece
Research Site

Athens, 15123, Greece
Research Site

Heraklion, 71500, Greece
Research Site

Larissa, 41110, Greece
Research Site

Pátrai, 26504, Greece
Research Site

Thessaloniki, 54636, Greece
Research Site

Thessaloniki, 57010, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.